Arpida

Arpida AG

This biopharmaceutical company develops novel antibiotics for hospital patients to treat severe infections caused by drug-resistant bacteria.

Abgentis

This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Peninsula Pharmaceuticals

The company develops and commercialises broad-spectrum antibiotics to treat patients with life-threatening infections, including hospital-acquired pneumonia and urinary tract infections.

Adjutecpharma

This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.